Table 3.
DEPRESSION (PHQ-9) | ANXIETY (GAD-7) | DISTRESS (IES-R) | |||||||
---|---|---|---|---|---|---|---|---|---|
Affected No.(%) | Odds-ratio (95%IC) a | P-value | Affected No.(%) | Odds-ratio (95%IC) a | P-value | Affected No.(%) | Odds-ratio (95%IC) a | P-value | |
Gender | |||||||||
Male | – | – | – | 47 (27.98) | 1 [REFERENCE] | NA | 43 (25.6) | 1 [REFERENCE] | NA |
Female | – | – | – | 212 (42.4) | 1.92 (1.30–2.88) | .001 | 203 (40.6) | 1.98 (1.34–2.99) | < .001 |
Precarious situation | |||||||||
No | 170 [36.56] | 1 [REFERENCE] | NA | 167 (35.91) | 1 [REFERENCE] | NA | 151 (32.47) | 1 [REFERENCE] | NA |
Yes | 85 [41.87] | 1.02 (0.71–1.46) | .91 | 92 (45.32) | 1.20 (0.84–1.71) | .31 | 95 (46.8) | 1.6 (1.12–2.27) | .009 |
Job | |||||||||
No | 214 [40.68] | 1 [REFERENCE] | NA | 224 (42.58) | 1 [REFERENCE] | NA | 209 (39.73) | 1 [REFERENCE] | NA |
Yes | 41 [28.87] | 0.99 (0.60–1.61) | .96 | 35 (24.65) | 0.61 (0.37–1) | .05 | 37 (26.06) | 0.80 (0.48–1.31) | .39 |
Study Years Clinical activities | |||||||||
1st year MS - no clinical activities | 171 (51.20) | 1 [REFERENCE] | NA | 166 (49.70) | 1 [REFERENCE] | NA | 155 (46.41) | 1 [REFERENCE] | NA |
MS - one per week | 28 (22.05) | 0.24 (0.14–0.39) | < .001 | 30 (23.44) | 0.34 (0.21–0.54) | < .001 | 38 (29.69) | 0.54 (0.34–0.84) | .007 |
MS - half time | 47 (28.31) | 0.32 (0.18–0.54) | < .001 | 52 (31.52) | 0.55 (0.36–0.83) | .005 | 41 (24.85) | 0.42 (0.27–0.65) | < .001 |
MS - Full time hospital | 9 (21.95) | 0.19 (0.06–0.49) | .001 | 11 (26.83) | 0.53 (0.22–1.2) | .13 | 12 (29.27) | 0.60 (0.26–1.35) | .23 |
COVID19 symptoms | |||||||||
No symptoms | 201 (36.68) | 1 [REFERENCE] | NA | – | – | – | – | – | – |
COVID19 symptoms | 38 (42.22) | 1.56 (0.94–2.52) | .07 | – | – | – | – | – | – |
COVID19 diagnosis | 16 (53.33) | 2.61 (1.21–6.13) | .016 | – | – | – | – | – | – |
Legend: PHQ-9, 9-item Patient Health Questionnaire; GAD-7, 7-item Generalized Anxiety Disorder; IES-R, 22-item Impact of Event Scale-Revised.
Associated factors (p < .20) in the bivariate analyses were included. (see Supplementary material S1).